[1] |
詹姆斯H. 约根森, 迈克尔A. 普法勒主编; 王辉等译. 临床微生物学手册(第11版)[M]. 北京: 中华医学电子音像出版社,2017,6:1214-1215.
|
[2] |
Braun V, Hundsberger T, Leukel P, et al. Definition of the single intergration site of the pathogenicity locus in Clostridium difficile[J]. Gene,1996,181(1-2):29-38.
|
[3] |
Peniche AG, Savidge TC, Dann SM. Recent insights into Clostridium difficile pathogenesis[J]. Curr Opin Infect Dis,2013,26(5):447-453.
|
[4] |
牛敏,刘淑敏,杜艳. 溃疡性结肠炎患者粪便中艰难梭菌毒素基因A/B携带情况的研究[J]. 国际检验医学杂志,2017,38(4):436-438.
|
[5] |
王虑,何超. 多发伤合并伪膜性肠炎1例报道[J]. 亚太传统医药,2010,6(6):90-91.
|
[6] |
Bloomfield LE, Riley TV. Epidemiology and risk factors for community-associated Clostridium difficile infection: a narrative review[J]. Infect Dis Ther,2016,5(3):231-251.
|
[7] |
Vardakas KZ, Trigkidis KK, Boukouvala E, et al. Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials:a systematic review and meta-analysis[J]. Int J Antimicrob Agents,2016,48(1):1-10.
|
[8] |
Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults:a systematic review[J]. JAMA,2015,313(4):398-408.
|
[9] |
Li YT, Cai HF, Wang ZH, et al. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection[J]. Aliment Pharmacol Ther,2016,43(4):445-457.
|
[10] |
Li Y, Huang Y, Li Y, et al. Clinical characteristics of Clostridium difficile associated diarrhea among patients in a tertiary care center in China[J]. Pak J Med Sci,2016,32(3):736-741.
|
[11] |
王洁. 血液病患者产毒艰难梭菌定植和感染危险因素的前瞻性研究及临床分离艰难梭菌的耐药性分析[D]. 河北医科大学,2014.
|
[12] |
项迎春. 110例抗生素相关性腹泻的临床研究[J]. 中华医院感染学杂志,2012,22(4):814-816.
|
[13] |
Loo VG, Poirier L, Miller MA, Oughton M, et al. A predominantil clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality[J]. N Eegl J Med,2005,353(23):2442-2449.
|
[14] |
McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene variant strain of Clostridium difficile[J]. N Eegl J Med,2005,353(23):2433-2441.
|
[15] |
Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infect[J]. Clin Infect Dis,2008,46(Suppl 1):S12-S18.
|
[16] |
Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection[J]. Clin Infect Dis,2008,46(Suppl 1):S12-S18.
|
[17] |
Zucca M, Scutera S, Savoia D. Novel avenues for Clostridium difficile infection drug discovery[J]. Expert Opin Drug Discov,2013,8(4):459-477.
|
[18] |
梁桐尔,王烜. 艰难梭菌和炎症性肠病相关性研究进展[J]. 实用医学杂志,2015,31(22):3802-3804.
|
[19] |
Ritter AS, Petri WA Jr. New developments in chemotherapeutic options for Clostridium difficile colitis[J]. Curr Opin Infect Dis,2013,26(5):461-470.
|
[20] |
Martin J, Mawer D, Wilcox MH. Clostridium difficile: biological therapies[J]. Curr Opin Infect Dis,2013,26(5):454-460.
|